发明名称 |
Liquid preparation comprising pimobendan |
摘要 |
The invention relates to novel liquid preparation comprising a substituted benzimidazol, preferably pimobendan as pharmaceutically active compound. In particular, the present invention relates to liquid preparation comprising an etherified cyclodextrin derivative, preferably in a concentration of about 20 to 70% (w/v) and said substituted benzimidazol, preferably in a concentration of about 0.005 to 0.15% (w/w). |
申请公布号 |
US9107952(B2) |
申请公布日期 |
2015.08.18 |
申请号 |
US200711935129 |
申请日期 |
2007.11.05 |
申请人 |
Boehringer Ingelheim Vetmedica GmbH |
发明人 |
Folger Martin;Lehner Stefan |
分类号 |
A61K31/501;A61P9/00;A61K47/40;A61K9/00;A61K9/08;A61K47/48;B82Y5/00 |
主分类号 |
A61K31/501 |
代理机构 |
|
代理人 |
Morris Michael P.;Gombert Wendy M. |
主权项 |
1. A liquid preparation comprising:
about 20 to 30% (w/v) of an etherified cyclodextrin derivative selected from the group consisting of alpha-, beta- and gamma-cyclodextrin ethers; and about 0.075 to 0.1% (w/v) of pimobendan or a pharmaceutically acceptable salt thereof, wherein the molar ratio of pimobendan or the pharmaceutically acceptable salt thereof to the etherified cyclodextrin derivative is about 1:47 to about 1:96. |
地址 |
Ingelheim am Rhein DE |